Leef Brands (LEEEF) EPS (Basic) (2025 - 2026)
Leef Brands (LEEEF) reported EPS (Basic) of -$0.0 for Q1 2026, down 207.89% on a YoY basis from $0.0 in Q1 2025, and down 207.89% sequentially from $0.0 in Q1 2025.
Leef Brands (LEEEF) EPS (Basic) (2025 - 2026) Analysis & Trends
Leef Brands (LEEEF) has 2 years of EPS (Basic) data on file, last reported at -$0.0 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 207.89% year-over-year to -$0.0; the trailing twelve-month figure through Mar 2026 stood at -$0.0 (changed N/A YoY), and the FY2025 full-year result was -$0.1, up 45.07% from the prior year.
- EPS (Basic) retreated to -$0.0 in Q1 2026, from $0.0 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.0 in Q1 2025 to a low of -$0.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 6.32 |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 0.11 |
| 10 | Leef Brands | 51.81 Mn | 46.05 Mn | 4.62 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Mar 31, 2025 | 0.00 |